CIK 0000784199 · Large accelerated filer
ARTIVION, INC.
Sign in to watch- Ticker
- AORT
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 592417093
- Phone
- 7704193355
- Business address
- 1655 ROBERTS BOULEVARD N W, KENNESAW, GA, 30144
- Former names
- CRYOLIFE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,529,843
- in 3 filings
Net −$2,529,843. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-06 | Mackin James P President & CEO | Option exercise · Stock Options (Right to buy) 10b5-1 | −75,615 | 0 | ||
| 2025-03-06 | Horton Amy VP, Chief Accounting Officer | Grant or award | +10,261 | 147,699 | ||
| 2025-03-06 | Horton Amy VP, Chief Accounting Officer | Sale | −1,048 | $24.80 | $26K | 146,651 |
| 2025-03-06 | Berry Lance A Executive VP, CFO | Grant or award | +48,100 | 158,340 | ||
| 2025-03-06 | Berry Lance A Executive VP, CFO | Sale | −4,909 | $24.80 | $122K | 153,431 |
| 2025-03-06 | Davis John E Chief Commercial Officer | Grant or award | +25,654 | 210,586 | ||
| 2025-03-06 | Davis John E Chief Commercial Officer | Sale | −2,618 | $24.80 | $65K | 207,968 |
| 2025-03-06 | Stanton Marshall S. SVP, Clinical & MD Affair | Grant or award | +19,240 | 117,483 | ||
| 2025-03-06 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | −1,603 | $24.80 | $40K | 115,880 |
| 2025-03-06 | Holloway Jean F SVP, General Counsel | Grant or award | +25,493 | 198,236 | ||
| 2025-03-06 | Holloway Jean F SVP, General Counsel | Sale | −2,124 | $24.80 | $53K | 196,112 |
| 2025-03-05 | Holloway Jean F SVP, General Counsel | Sale | −472 | $25.29 | $12K | 172,743 |
| 2025-03-05 | SEMEDO ANTHONY B. Director | Purchase | +1,500 | $25.33 | $38K | 35,659 |
| 2025-03-05 | SEMEDO ANTHONY B. Director | Purchase | +600 | $25.25 | $15K | 600 |
| 2025-02-28 | Stanton Marshall S. SVP, Clinical & MD Affair | Grant or award | +18,398 | 98,243 | ||
| 2025-02-28 | Mackin James P President & CEO | Grant or award | +98,524 | 762,406 | ||
| 2025-02-28 | Horton Amy VP, Chief Accounting Officer | Grant or award | +6,297 | 137,438 | ||
| 2025-02-28 | Holloway Jean F SVP, General Counsel | Grant or award | +23,416 | 173,215 | ||
| 2025-02-28 | Davis John E Chief Commercial Officer | Grant or award | +24,301 | 184,932 | ||
| 2025-02-28 | Berry Lance A Executive VP, CFO | Grant or award | +34,435 | 110,240 |
Page 9 of 11 · 201 trades